BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Spectral Molecular Imaging, a wholly-owned subsidiary of Cascade Technologies, Inc. (OTCBB: CSDT), has appointed Gregory Bearman, Ph.D., to the position of Chief Scientist, where he will guide development of a range of imaging devices for the earlier detection of cancer and other major disease, based on the Company's proprietary optical imaging technologies.
